211 related articles for article (PubMed ID: 25052159)
1. Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
Papa L; Robertson CS; Wang KK; Brophy GM; Hannay HJ; Heaton S; Schmalfuss I; Gabrielli A; Hayes RL; Robicsek SA
Neurocrit Care; 2015 Feb; 22(1):52-64. PubMed ID: 25052159
[TBL] [Abstract][Full Text] [Related]
2. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
[TBL] [Abstract][Full Text] [Related]
3. Temporal Profile of Microtubule-Associated Protein 2: A Novel Indicator of Diffuse Brain Injury Severity and Early Mortality after Brain Trauma.
Papa L; Robicsek SA; Brophy GM; Wang KKW; Hannay HJ; Heaton S; Schmalfuss I; Gabrielli A; Hayes RL; Robertson CS
J Neurotrauma; 2018 Jan; 35(1):32-40. PubMed ID: 28895474
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
[TBL] [Abstract][Full Text] [Related]
5. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
Mondello S; Robicsek SA; Gabrielli A; Brophy GM; Papa L; Tepas J; Robertson C; Buki A; Scharf D; Jixiang M; Akinyi L; Muller U; Wang KK; Hayes RL
J Neurotrauma; 2010 Jul; 27(7):1203-13. PubMed ID: 20408766
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.
Mondello S; Linnet A; Buki A; Robicsek S; Gabrielli A; Tepas J; Papa L; Brophy GM; Tortella F; Hayes RL; Wang KK
Neurosurgery; 2012 Mar; 70(3):666-75. PubMed ID: 21937927
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
[TBL] [Abstract][Full Text] [Related]
9. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.
Brophy GM; Mondello S; Papa L; Robicsek SA; Gabrielli A; Tepas J; Buki A; Robertson C; Tortella FC; Hayes RL; Wang KK
J Neurotrauma; 2011 Jun; 28(6):861-70. PubMed ID: 21309726
[TBL] [Abstract][Full Text] [Related]
10. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.
Czeiter E; Mondello S; Kovacs N; Sandor J; Gabrielli A; Schmid K; Tortella F; Wang KK; Hayes RL; Barzo P; Ezer E; Doczi T; Buki A
J Neurotrauma; 2012 Jun; 29(9):1770-8. PubMed ID: 22435839
[TBL] [Abstract][Full Text] [Related]
11. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
12. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
[TBL] [Abstract][Full Text] [Related]
13. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
[TBL] [Abstract][Full Text] [Related]
14. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.
Papa L; Lewis LM; Silvestri S; Falk JL; Giordano P; Brophy GM; Demery JA; Liu MC; Mo J; Akinyi L; Mondello S; Schmid K; Robertson CS; Tortella FC; Hayes RL; Wang KK
J Trauma Acute Care Surg; 2012 May; 72(5):1335-44. PubMed ID: 22673263
[TBL] [Abstract][Full Text] [Related]
16. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.
Goyal A; Failla MD; Niyonkuru C; Amin K; Fabio A; Berger RP; Wagner AK
J Neurotrauma; 2013 Jun; 30(11):946-57. PubMed ID: 23190274
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers versus glasgow coma scale and glasgow outcome scale in pediatric traumatic brain injury: the role of young age and inflicted injury.
Shore PM; Berger RP; Varma S; Janesko KL; Wisniewski SR; Clark RS; Adelson PD; Thomas NJ; Lai YC; Bayir H; Kochanek PM
J Neurotrauma; 2007 Jan; 24(1):75-86. PubMed ID: 17263671
[TBL] [Abstract][Full Text] [Related]
18. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
Brennan PM; Murray GD; Teasdale GM
J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
[TBL] [Abstract][Full Text] [Related]
19. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
20. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury.
Cardali S; Maugeri R
J Neurosurg Sci; 2006 Jun; 50(2):25-31. PubMed ID: 16841024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
